Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of SHR-4597 Inhalants in Adults With Asthma
NCT06940700Phase 2Not yet recruiting
- Sponsor
- Hengrui Therapeutics
- Start
- Apr 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SHR-4597 in asthma, sponsored by Hengrui Therapeutics. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
SHR-4597
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06940700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06940700.